Evidence map›Paper›PMID 17093036›Full record

ArticleJournal of clinical microbiology2007

Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone.

M Catherine McEllistrem, Jennifer V Ransford, Saleem A Khan

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Phase Variation ofMicrobiology spectrum · 2019
    Article
  5. Rutin InhibitsFrontiers in pharmacology · 2017
    Article
  6. New Technologies for Studying Biofilms.Microbiology spectrum · 2015
    Review
  7. Article
  8. Biofilm formation in Streptococcus pneumoniae.Microbial biotechnology · 2012
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M Catherine McEllistremDivision of Infectious Diseases, University of Pittsburgh School of Medicine, PA 15213-2582, USA. mcellistremc@dom.pitt.edu
Jennifer V Ransford
Saleem A Khan
University of Pittsburgh · US

Funding

PREVENTION OF PNEUMOCOCCAL DISEASE IN HIV INFECTIONK23AI001788 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCELLISTREM, MARY C · 2000 to 2004
$623k
NIAID NIH HHS K23 AI001788NIAID NIH HHS K23 AI01788
6 · The paper itself

Abstract

An increasing proportion of children with acute otitis media due to Streptococcus pneumoniae have serotype 3 infections since licensure of the seven-valent pneumococcal conjugate vaccine. These serotype 3 strains are genetically related by molecular subtyping. During otitis media with effusion and recurrent otitis media, biofilms commonly develop. Pneumococcal in vitro biofilms are comprised of phase variants that differ in colony morphology. By using a representative strain of the mucoid serotype 3 clone, rough phase variants with a diverse array of mutations were detected in biofilms formed in vitro. Most phase variants had mutations in the cps3D gene, the first gene of the capsular operon. Eleven had single nucleotide polymorphisms (SNPs) in the cps3D gene, one had an SNP in the -10 promoter, and three had large deletions in the cps3D gene. Reversion to the mucoid phenotype was associated with reversion of the mutation in the cps3D gene. Unlike the phase variants detected in the nasopharynx, which have at least 20% of the parental amount of capsule, the in vitro biofilm-associated phase variants had < or =12% of the parental amount of capsule, as determined by capsule enzyme-linked immunosorbent assays. Using real-time reverse transcription-PCR, we determined that capsule expression in the phase variants was likely regulated at multiple levels. These in vitro phase variation data, which underscore the plasticity of the pneumococcus, need to be confirmed with in vivo analyses of the middle ear mucosa during otitis media.

Indexed as

Gene Expression Regulation, BacterialBacterial CapsulesBacterial ProteinsBiofilmsEnzyme-Linked Immunosorbent AssayGenotypeHumansMutationOtitis MediaPneumococcal InfectionsReverse Transcriptase Polymerase Chain ReactionStreptococcus pneumoniaeUridine Diphosphate Glucose DehydrogenaseBacterial ProteinsCap3a protein, Streptococcus pneumoniaeUridine Diphosphate Glucose Dehydrogenase

Identifiers

PMID17093036
PMCPMC1828957
OpenAlexW2168736186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.